Inoviq Ltd has released a press release.
Pause in Trade
Filed with ASX ·
On 6ix: 6ix.com/news/pause-in-trade-10
6ix hasn’t read this filing yet.
Earlier from Inoviq
- Quarterly Business Update and Appendix 4C - March 2025
- Appendix 4D and FY25 Half Year Financial Report
- Quarterly Business Update and Appendix 4C - December 2024
- Weaponising Exosomes for Breast Cancer treatment
- Disease Specificity study completed for NeuCA15-3 test
Later from Inoviq
- Response to ASX Price Query
- Suspension from Quotation
- Early Ovarian Cancer Screening Breakthrough
- Reinstatement to Official Quotation
- New treatment kills 88% of Breast and Lung Cancer cells
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq